Aysegul Idil Soylu

Dr. Aysegul Idil Soylu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ASAysegul Idil Soylu
Aysegul Idil Soylu
KSKorhan Soylu
Korhan Soylu
RARamazan Aydin
Ramazan Aydin
FUFatih Uzunkaya
Fatih Uzunkaya
KAKerim Aslan
Kerim Aslan
APAhmet Veysel Polat
Ahmet Veysel Polat
Https://orcid.org/0000-0002-9740-3580 A total of 404 female patients above 40 years of age who, within a 6-month period, had undergone thoracic computed tomography and mammography for various reasons were screened retrospectively at our clinic. Mammographies were assessed for BAC and thoracic CT investigations were assessed for CAC and AC. Patients included in the study were scored as 0 (none), 1 (mild), 2 (moderate), or 3 (severe) depending on the number and shape of CAC, AC, and BAC lesions observed. Four hundred and four females were enrolled in the study. While BAC was detected in 123 patients, no BAC was observed in the other 281 patients. In the BAC-positive patients, the rates of CAC (45.5% vs. 19.9%, P < 0.001) and AC (67.5% vs. 32.4%, P < 0.001) were notably higher than in the BAC-negative patients. In addition, multivariate regression analysis detected the presence of BAC as an independent variable for both CAC and AC. The presence of BAC appeared to be a significant risk factor for CAC and AC, and the BAC grade was considered an independent risk factor for CAC.

21 August 2019 in Minimally Invasive Therapy & Allied Technologies
Verified
Journal Article
Closed access
ASAysegul Idil Soylu
Aysegul Idil Soylu
FUFatih Uzunkaya
Fatih Uzunkaya
ÜBÜmit Belet
Ümit Belet
HAHüseyin Akan
Hüseyin Akan
Introduction: Selective transarterial embolization (STAE) is a minimally invasive treatment method developed as am alternative to surgery for acute renal haemorrhage (ARH). The aim of this study was to evaluate the efficacy and outcome of STAE in ARH patients. Material and methods: The data of patients who underwent STAE with signs of ARH were collected retrospectively. The etiology of renal haemorrhage, localization and type of lesion, embolizing agent used, the amount of contrast material given, duration of fluoroscopy and perioperative and postoperative complications were recorded. Lesions were classified as pseudoaneurysm (PA), arteriovenous fistula (AVF), arterio pelvic fistula (ACF), pathological tumoral vasculature and extravasation. Results: A total of 51 patients were included in the study. The most common symptom was gross hematuria (76.4%) and the most common underlying cause was iatrogenic renal injury (64.7%). Embolizing agents used were n-BCA-iodized oil in 29 patients, coils alone in six patients, coils + n-BCA in four patients, ethanol-iodized oil in three patients, combination of n-BCA-iodized oil and ethanol-iodized oil in two patients, polyvinyl alcohol particles in three patients and covered stent in one patient. Technical success was 100% in all patients and there was no need for reintervention. Conclusions: STAE is a safe, effective and minimally invasive method in emergency treatment of ARH.

18 June 2021 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
ASAysegul Idil Soylu
Aysegul Idil Soylu
FUFatih Uzunkaya
Fatih Uzunkaya
HAHüseyin Akan
Hüseyin Akan

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
FUFatih Uzunkaya
Fatih Uzunkaya
ASAysegul Idil Soylu
Aysegul Idil Soylu
The knowledge of factors influencing functional outcomes after aneurysmal subarachnoid hemorrhage (ASH) has significantly increased in recent decades, still not enough. We aimed to identify the predictors of full functional recovery (FFR) in endovascularly treated patients with ASH. A retrospective review was performed of adult patients who underwent endovascular treatment for ASH in a five-year period. The association was evaluated of variables with FFR, defined as a modified Rankin Scale score of 0 or 1 at a 3-month follow-up. This study included 204 patients with a percentage of FFR of 62.7%. On univariate analysis, the following variables were associated with FFR: younger age, male sex, no history of hypertension, posterior circulation aneurysm, better modified-Fisher grade (mFG), better Hunt-Hess grade, better Glasgow Coma score, lower platelet-to-lymphocyte ratio (PLR), lower neutrophil-to-lymphocyte ratio (NLR) and higher platelet-to-neutrophil ratio (PNR). On multivariate analysis, younger age (OR = 0.95, 95% Cl = 0.92-0.98, p = 0.003), better mFG (OR = 0.66, 95% Cl = 0.48-0.97, p = 0.03), lower PLR (OR = 0.993, 95% Cl = 0.990-0.997, p = 0.001), lower NLR (OR = 0.89, 95% Cl = 0.83-0.95, p = 0.01) and higher PNR (OR = 1.08, 95% Cl = 1.01-1.10, p = 0.01) showed the strongest association with FFR. With the administration of endovascular treatment, most of the patients with ASH can return to a normal productive life. Younger age, better mFG, lower PLR and NLR, as well as higher PNR, increase the likelihood of FFR.

4 October 2021 in European Journal of Breast Health
Verified
Journal Article
Closed access
ASAysegul Idil Soylu
Aysegul Idil Soylu
MÖMesut Öztürk
Mesut Öztürk
APAhmet Veysel Polat
Ahmet Veysel Polat
The purpose of this study was to look into the relationship between breast size and mammographic breast density in women and breast radiation dose on full-field digital mammography (FFDM), as well as the factors that influence radiation dose. The study included a total of 2,060 FFDM images from 515 consecutive participants. The participants were divided into two groups: those exposed to high doses (>3 mGy) and those exposed to low doses (<3 mGy). Moreover, the researchers analyzed the relationship between mean glandular dose (MGD) of the breast and patient age, compressed breast thickness, compression force, mammographic breast composition, and mammographic breast size. The mean mammographic breast volume was 936.2 ± 425.2 (114.5–3,018) mL, and the mean compressed breast tissue thickness was 56.75 ± 10.44 mm. Moreover, the mean MGD in the high-dose group was 3.51 ± 0.48 mGy and 1.92 ± 0.56 mGy in the low-dose group. The high-dose group had greater breast thickness, diameters, volume, compression pressure, and surgical rate. However, the high-dose group was younger and had less dense breasts. In multivariate logistic regression analysis, the most important predictors of dose determination were breast thickness [odds ratio (OR): 1.178, 95% confidence interval (CI): 1.156–1.200, p<0.001], history of previous surgery (OR: 2.210, 95% CI: 1.417–3.447, p<0.001), compression force (OR: 1.008, 95% CI: 1.004–1.013, p<0.001), and breast density (OR: 1.873, 95% CI: 1.359–2.580, p<0.001). Women with larger breast volumes are subjected to higher doses of radiation. Therefore, breast-screening programs can be individualized to young women with larger breast volumes and women who have had breast-conserving surgery.

1 March 2021 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
PDF file
ASAysegul Idil Soylu
Aysegul Idil Soylu
UAUfuk Avcıoglu
Ufuk Avcıoglu
FUFatih Uzunkaya
Fatih Uzunkaya
KSKorhan Soylu
Korhan Soylu
The aim of this study is to evaluate the mesenteric artery stenosis (MAS) in routinely performed CT angiography (CTA) of patients with severe aortic stenosis (AS) planned for transcatheter aortic valve implantation (TAVI) before the procedure. Patients with AS (AS group) who routinely underwent CTA before the TAVI procedure due to severe AS and patients who had CTA for other indications (control group) were retrospectively and sequentially scanned. The demographic characteristics of the patients in both groups were similar. Calcification and stenosis in the mesenteric arteries were recorded according to the localization of celiac truncus, superior mesenteric artery (SMA) and inferior mesenteric artery (IMA). Class 0-3 classification was used for calcification score. Stenoses with a stenosis degree ≥50% were considered as significant. A total of 184 patients, 73 patients with severe AS and 111 control groups, were included in the study. SMA and IMA calcification scores of patients with AS were significantly higher than the control group (p=0.035 for SMA and p=0.020 for IMA). In addition, the rate of patients with significant MAS in at least 1 artery (45.2% vs 22.5%, p=0.001) and the rate of patients with significant stenosis in multiple arteries were also significantly higher in the AS group (8.2% vs 1.8%, p=0.037). According to the study results, patients with AS are at a higher risk for MAS. Chronic mesenteric ischemia should be kept in mind in patients with AS who have symptoms such as non-specific abdominal pain and weight loss.